DrugPatentWatch Database Preview
Bupivacaine hydrochloride - Generic Drug Details
» See Plans and Pricing
What are the generic sources for bupivacaine hydrochloride and what is the scope of patent protection?
Bupivacaine hydrochloride
is the generic ingredient in twelve branded drugs marketed by Innocoll Pharms, Aurobindo Pharma Ltd, Hospira, Mylan Asi, Novocol Healthcare, Intl Medicated, Fresenius Kabi Usa, B Braun Medical Inc, Baxter Hlthcare Corp, Huons, Septodont, and Amphastar Pharms Inc, and is included in forty-one NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.Bupivacaine hydrochloride has twenty-six patent family members in fifteen countries.
There are twelve drug master file entries for bupivacaine hydrochloride. Thirteen suppliers are listed for this compound.
Summary for bupivacaine hydrochloride
International Patents: | 26 |
US Patents: | 1 |
Tradenames: | 12 |
Applicants: | 12 |
NDAs: | 41 |
Drug Master File Entries: | 12 |
Suppliers / Packagers: | 13 |
Bulk Api Vendors: | 94 |
Clinical Trials: | 1,280 |
Patent Applications: | 910 |
Formulation / Manufacturing: | see details |
What excipients (inactive ingredients) are in bupivacaine hydrochloride? | bupivacaine hydrochloride excipients list |
DailyMed Link: | bupivacaine hydrochloride at DailyMed |
Recent Clinical Trials for bupivacaine hydrochloride
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Laval University | Phase 3 |
CHU de Quebec-Universite Laval | Phase 3 |
The Geneva Foundation | N/A |
Pharmacology for bupivacaine hydrochloride
Drug Class | Amide Local Anesthetic alpha-Adrenergic Agonist beta-Adrenergic Agonist Catecholamine |
Mechanism of Action | Adrenergic alpha-Agonists Adrenergic beta-Agonists |
Physiological Effect | Local Anesthesia |
US Patents and Regulatory Information for bupivacaine hydrochloride
International Patents for bupivacaine hydrochloride
Country | Patent Number | Estimated Expiration |
---|---|---|
Japan | 2010522738 | Start Trial |
World Intellectual Property Organization (WIPO) | 2008117268 | Start Trial |
Ireland | S20080229 | Start Trial |
Ireland | 20070220 | Start Trial |
Hungary | E043185 | Start Trial |
Portugal | 3085363 | Start Trial |
>Country | >Patent Number | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:






Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.